Aclaris Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
November 16 2020 - 4:01PM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
management will participate in a virtual fireside chat at the
Evercore ISI 3rd Annual HealthCONx Conference on Wednesday,
December 2, 2020 at 7:30 a.m. ET. Management will be available
December 1st and 2nd throughout the day for virtual one-on-one
meetings.
A live audio webcast of the fireside chat may be accessed
through the Events page under the Investors section of Aclaris’
website, www.aclaristx.com. An archived version of the webcast will
be available for 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Contact
investors@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024